Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective

被引:303
作者
Vickery, Brian P.
Berglund, Jelena P. [1 ]
Burk, Caitlin M.
Fine, Jason P.
Kim, Edwin H.
Kim, Jung In
Keet, Corinne A. [2 ]
Kulis, Michael
Orgel, Kelly G.
Guo, Rishu
Steele, Pamela H.
Virkud, Yamini V. [3 ]
Ye, Ping
Wright, Benjamin L. [4 ]
Wood, Robert A. [2 ]
Burks, A. Wesley
机构
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Mayo Clin, Scottsdale, AZ USA
基金
美国国家卫生研究院;
关键词
Oral immunotherapy; desensitization; sustained unresponsiveness; early intervention; peanut allergy; randomized clinical trial; NATURAL-HISTORY; FOOD ALLERGY; DOUBLE-BLIND; EGG ALLERGY; IGE LEVELS; HIGH-RISK; INFANTS; DESENSITIZATION; PREDICTORS; RESOLUTION;
D O I
10.1016/j.jaci.2016.05.027
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Oral immunotherapy (OIT) is an effective experimental food allergy treatment that is limited by treatment withdrawal and the frequent reversibility of desensitization if interrupted. Newly diagnosed preschool children may have clinical and immunological characteristics more amenable to treatment. Objective: We sought to test the safety, effectiveness, and feasibility of early OIT (E-OIT) in the treatment of peanut allergy. Methods: We enrolled 40 children aged 9 to 36 months with suspected or known peanut allergy. Qualifying subjects reacted to peanut during an entry food challenge and were block randomized 1: 1 to receive E-OIT at goal maintenance doses of 300 or 3000 mg/d in a double-blinded fashion. The primary end point, sustained unresponsiveness at 4 weeks after stopping early intervention oral immunotherapy (4-SU), was assessed by double blinded, placebo-controlled food challenge either upon achieving 4 prespecified criteria, or after 3 maintenance years. Peanut-specific immune responses were serially analyzed. Outcomes were compared with 154 matched standard-care controls. Results: Of 40 consented subjects, 3 (7.5%) did not qualify. Overall, 29 of 37 (78%) in the intent-to-treat analysis achieved 4-SU (300-mg arm, 17 of 20 [85%]; 3000 mg, 12 of 17 [71%], P =.43) over a median of 29 months. Per-protocol, the overall proportion achieving 4-SU was 29 of 32 (91%). Peanut-specific IgE levels significantly declined in E-OIT-treated children, who were 19 times more likely to successfully consume dietary peanut than matched standard-care controls, in whom peanut-specific IgE levels significantly increased (relative risk, 19.42; 95% CI, 8.7-43.7; P < .001). Allergic side effects during E-OIT were common but all were mild to moderate. Conclusions: At both doses tested, E-OIT had an acceptable safety profile and was highly successful in rapidly suppressing allergic immune responses and achieving safe dietary reintroduction.
引用
收藏
页码:173 / +
页数:17
相关论文
共 39 条
[1]   Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial [J].
Anagnostou, Katherine ;
Islam, Sabita ;
King, Yvonne ;
Foley, Loraine ;
Pasea, Laura ;
Bond, Simon ;
Palmer, Chris ;
Deighton, John ;
Ewan, Pamela ;
Clark, Andrew .
LANCET, 2014, 383 (9925) :1297-1304
[3]  
Bird JA, 2015, ALLERGY, V70, P110
[4]   Oral Immunotherapy for Treatment of Egg Allergy in Children [J].
Burks, A. Wesley ;
Jones, Stacie M. ;
Wood, Robert A. ;
Fleischer, David M. ;
Sicherer, Scott H. ;
Lindblad, Robert W. ;
Stablein, Donald ;
Henning, Alice K. ;
Vickery, Brian P. ;
Liu, Andrew H. ;
Scurlock, Amy M. ;
Shreffler, Wayne G. ;
Plaut, Marshall ;
Sampson, Hugh A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03) :233-243
[5]   Altered T-cell receptor signaling in the pathogenesis of allergic disease [J].
Datta, Shrimati ;
Milner, Joshua D. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) :351-354
[6]   Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy [J].
Du Toit, George ;
Roberts, Graham ;
Sayre, Peter H. ;
Bahnson, Henry T. ;
Radulovic, Suzana ;
Santos, Alexandra F. ;
Brough, Helen A. ;
Phippard, Deborah ;
Basting, Monica ;
Feeney, Mary ;
Turcanu, Victor ;
Sever, Michelle L. ;
Lorenzo, Margarita Gomez ;
Plaut, Marshall ;
Lack, Gideon .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :803-813
[7]   Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study [J].
Du Toit, George ;
Roberts, Graham ;
Sayre, Peter H. ;
Plaut, Marshall ;
Bahnson, Henry T. ;
Mitchell, Herman ;
Radulovic, Suzana ;
Chan, Susan ;
Fox, Adam ;
Turcanu, Victor ;
Lack, Gideon .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) :135-U215
[8]   Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants [J].
Fleischer, David M. ;
Sicherer, Scott ;
Greenhawt, Matthew ;
Campbell, Dianne ;
Chan, Edmond ;
Muraro, Antonella ;
Halken, Susanne ;
Katz, Yitzhak ;
Ebisawa, Motohiro ;
Eichenfield, Lawrence ;
Sampson, Hugh ;
Lack, Gideon ;
Du Toit, George ;
Roberts, Graham ;
Bahnson, Henry ;
Feeney, Mary ;
Hourihane, Jonathan ;
Spergel, Jonathan ;
Young, Michael ;
As'aad, Amal ;
Allen, Katrina ;
Prescott, Susan ;
Kapur, Sandeep ;
Saito, Hirohisa ;
Agache, Ioana ;
Akdis, Cezmi A. ;
Arshad, Hasan ;
Beyer, Kirsten ;
Dubois, Anthony ;
Eigenmann, Philippe ;
Fernandez-Rivas, Monserrat ;
Grimshaw, Kate ;
Hoffman-Sommergruber, Karin ;
Host, Arne ;
Lau, Susanne ;
O'Mahony, Liam ;
Mills, Clare ;
Papadopoulos, Nikolaus ;
Venter, Carina ;
Agmon-Levin, Nancy ;
Kessel, Aaron ;
Antaya, Richard ;
Drolet, Beth ;
Rosenwasser, Lanny .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (02) :258-261
[9]   The natural progression of peanut allergy: Resolution and the possibility of recurrence [J].
Fleischer, DM ;
Conover-Walker, MK ;
Christie, L ;
Burks, AW ;
Wood, RA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (01) :183-189
[10]   Suppression of the immunologic response to peanut during immunotherapy is often transient [J].
Gorelik, Mark ;
Narisety, Satya D. ;
Guerrerio, Anthony L. ;
Chichester, Kristin L. ;
Keet, Corinne A. ;
Bieneman, Anja P. ;
Hamilton, Robert G. ;
Wood, Robert A. ;
Schroeder, John T. ;
Frischmeyer-Guerrerio, Pamela A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (05) :1283-1292